Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Plos One|October 26, 2023
RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samplesKai Song, Emon Elboudwarej, Xi Zhao, et al.
Breast Cancer Research and Treatment|September 6, 2005
Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cellsJack F Youngren, Karissa Gable, Cristina Penaranda, et al.
Plos One|April 15, 2025
Trop-2 expression in non-small cell lung cancerPeiwen Kuo, Emon Elboudwarej, Marianna Zavodovskaya, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogsJoseph E Blecha, Marc O Anderson, Jennifer M Chow, et al.
The Prostate|May 21, 2008
Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cellsCharles J Ryan, Marianna Zavodovskaya, Jack F Youngren, et al.
Journal of Cellular Biochemistry|June 15, 2007
Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cellsMarianna Zavodovskaya, Michael J Campbell, Betty A Maddux, et al.
Molecular Cancer Therapeutics|May 2, 2006
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growthKarissa L Gable, Betty A Maddux, Cristina Penaranda, et al.
Journal for Immunotherapy of Cancer|February 6, 2023
Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumorsAnthony W Tolcher, Michael Gordon, Kathleen M Mahoney, et al.
Cancer Research Communications|July 14, 2026
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 StudyEnriqueta Felip, Peiwen Kuo, Pilar Garrido, et al.
Scientific Reports|June 30, 2022
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinomaAkira Ooki, Taroh Satoh, Kei Muro, et al.
Pageof 2